Hra Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HRA PHARMA, and what generic and branded alternatives to HRA PHARMA drugs are available?
HRA PHARMA has two approved drugs.
Drugs and US Patents for Hra Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hra Pharma | METOPIRONE | metyrapone | CAPSULE;ORAL | 012911-002 | Aug 9, 1996 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
Hra Pharma | METOPIRONE | metyrapone | TABLET;ORAL | 012911-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Hra Pharma | LYSODREN | mitotane | TABLET;ORAL | 016885-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.